Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Genomic Health (GHDX)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
OPERATING METRICS
REVENUE SOURCES
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for GHDX as compared to
Top Competitors
Medical Laboratories & Research
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS (
See all
)
Revenue
►
110M
AVG
Number of Patents
►
2.00
Cost of Goods Sold (COGS)
►
27.2M
AVG
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
110M
AVG
EBITDA
►
-817K
LOW
Net Income
►
-9.07M
LOW
Revenue Growth
►
11.4%
AVG
Operating Margin
►
-3.7%
AVG
Net Margin
►
-8.2%
AVG
Revenue, Gross Profit, and Gross Margin
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.341
AVG
Current Ratio
►
3.54
AVG
Quick Ratio
►
3.54
AVG
Interest Coverage Ratio
►
-38.3
AVG
Book Value Per Share
►
2.27
Cash Per Share
►
0.577
Loading...
STOCK SUMMARY
Open
18.80
Day Range
19.15
-
19.56
52 Week Range
15.81
-
27.22
Volume
2.59M
Avg Volume (3 mo)
103K
Shares Outstanding
29.0M
Market Cap
549M
VALUATION
Price to Earnings (P/E)
►
-60.9
Price to Book (P/B)
►
8.41
HIGH
Price to Sales (P/S)
►
5.02
AVG
Return on Assets (ROA)
►
-10.3%
AVG
Return on Equity (ROE)
►
-13.8%
AVG
EV/EBITDA
►
-696
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
-0.7%
Net Insider Buying 6mo
0.4%
Net Insider Buying 1yr
0.9%
Held by insiders
45.4%
Held by institutions
48.8%